Navigation Links
CardioDx to Present at the 12th Annual Needham Healthcare Conference
Date:4/23/2013

PALO ALTO, Calif., April 23, 2013 /PRNewswire/ -- CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the 12th Annual Needham Healthcare Conference on Tuesday, April 30, 2013 at 9:40 AM ET at the Westin Grand Central Hotel in New York. David Levison , the company's President and Chief Executive Officer, will provide an overview of CardioDx and Corus® CAD, the only clinically validated gene expression test for obstructive coronary artery disease (CAD).

(Logo: http://photos.prnewswire.com/prnh/20130219/MM60898)

CardioDx recently announced the publication of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression) study in Circulation: Cardiovascular Genetics, a journal of the American Heart Association. Results of the prospective, multi-center U.S. study showed that Corus CAD outperformed traditional stress testing with myocardial perfusion imaging (MPI), demonstrating high accuracy with both a higher sensitivity (89 percent vs. 27 percent) and higher negative predictive value (96 percent vs. 88 percent) than MPI for assessing the presence of obstructive CAD. 

With a simple blood draw, Corus CAD can safely, accurately and conveniently help primary care clinicians and cardiologists assess whether or not a stable non-diabetic patient's symptoms are due to obstructive CAD, enabling many patients to avoid unnecessary noninvasive and invasive cardiac procedures an
'/>"/>

SOURCE CardioDx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CardioDx to Present at Cowen and Company 33rd Annual Healthcare Conference
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
6. Foundation for Managed Care Pharmacy (FMCP) Presents Awards for 2012 National P&T Competition and Best Posters
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
8. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
9. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
10. Ultra Clean to Present at the Jefferies 2012 Global Technology, Media & Telcom Conference
11. Anlit to Present New Dietary Supplements for Children at Vitafoods Europe 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... 2014  Landauer, Inc. (NYSE: LDR ), ... and monitoring, outsourced medical physics services and high quality ... Saxelby , its President and Chief Executive Officer, will ... and as a member of the Board of Directors, ... replaced on an interim basis by Michael T. ...
(Date:8/22/2014)... Aug. 22, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) ... of units of common stock and warrants at a ... $20 million, prior to deducting underwriting discounts and commissions ... and warrants are immediately separable and will be issued ... begin trading on The NASDAQ Stock Market under the ...
(Date:8/21/2014)... Hermann Health System and The University of Texas ... to provide a new level of specialized breast screening at ... Houston area. Starting in ... professional breast radiology services for five of Memorial Hermann,s 10 ... Woodlands , Northeast, Southwest and Sugar Land ...
Breaking Medicine Technology:Landauer, Inc. Announces Executive Management Change 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4
... Roper Industries, Inc. (NYSE: ROP ) ... (CUSIP No. 776696AA4) (the "Notes") will accrue contingent interest for ... at an annual rate of 0.25% of the average market ... January 12, 2011. Contingent cash interest, which the Company has ...
... 18, 2011 Soligenix, Inc. (Soligenix or the ... a late-stage biopharmaceutical company, announced today promising preliminary ... beclomathasone dipropionate or BDP) in a canine gastrointestinal ... that dogs treated with SGX202 demonstrated statistically significant (p=0.04) ...
Cached Medicine Technology:Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury 2Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury 3Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury 4Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury 5
(Date:8/23/2014)... PA (PRWEB) August 23, 2014 "I ... when they gave a urine sample," said an inventor ... entire process easier and mess-free, I came up with ... to allow urine samples to be collected from women ... peace of mind to patients and staff. The invention ...
(Date:8/23/2014)... The report “Polycarbonate Resin Market ... to 2018” defines and segments the global polycarbonate ... global revenue and consumption. It also identifies driving ... market with analysis of trends, opportunities, burning issues, ... and revenues are forecasted on the basis of ...
(Date:8/23/2014)... August 23, 2014 Peripheral intervention surgeries ... remove plaques, etc, thereby addressing the root cause of ... of blood to the other part of the arteries ... blood. These procedures require the use of a catheter, ... and polymers), these catheters are inserted through a thin ...
(Date:8/23/2014)... Pittsburgh, PA (PRWEB) August 23, 2014 Having ... inventor and dental hygienist from Arlington, Texas, saw a need ... toothbrush and toothpaste. "That’s when I came up with the ... easy-to-use No-Brush provides an effective way for a user to ... the need to carry multiple items. It also helps avoid ...
(Date:8/23/2014)... Raleigh, NC (PRWEB) August 23, 2014 A ... IMRT for mesothelioma last longer when preceded by surgery and ... an article on the new study. Click here to ... Cancer Center studied the cases of mesothelioma patients ... technique for conforming radiotherapy dose to the shape of a ...
Breaking Medicine News(10 mins):Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 3Health News:Polycarbonate Resin Market by Applications and Geography Projected to $18.3 Billion by 2018 - New Report by MarketsandMarkets 4Health News:Global Peripheral Intervention Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Health News:Global Peripheral Intervention Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Health News:Global Peripheral Intervention Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 4Health News:New Study Links Hospital Experience and Prior Surgery with Mesothelioma Radiation Success, According to Surviving Mesothelioma 2
... Following is a,media statement attributable to Betsy ... Hospital Association:, "NJHA applauds the state upon ... This is a valuable document for New Jersey,s,hospitals ... a wealth of information on which hospitals can,focus ...
... Gaps in ... Breast Cancer Care, Survival, COLUMBUS, Ohio, Jan. 17 ... the Cure will host two events to,launch Ohio,s participation in the ... cancer care that cause some women to die,of the disease more ...
... Immunosyn,Corporation (OTC Bulletin Board: IMYN) announced today ... Concept Trial" for the biopharmaceutical SF-1019 has,been successfully ... The Board of Immunosyn was advised as ... "Proof of Concept Trial" by Argyll Biotechnologies, LLC ...
... of ongoing clinical trials, expert says , , THURSDAY, Jan. 17 ... or prevent Alzheimer,s disease, a new study finds no evidence ... suggested this possibility, whether the same benefit translates to humans ... find a relation between statin use and the risk of ...
... January 18 edition (Volume 28, Issue 1) of the journal ... is known as a nonsense mutation of the Coronin-1A gene ... mutation causes the gene to produce proteins that no longer ... cytoskeleton, a network of protein fibers or filaments in the ...
... from injuries, disease , THURSDAY, Jan. 17 (HealthDay ... creating the brain,s thinking center, in a finding that ... neurodegenerative diseases. , The gene, called Lhx2, tells stem ... cortex, which controls functions such as language, decision-making and ...
Cached Medicine News:Health News:Susan G. Komen for the Cure, U.S. Congressman Pat Tiberi, Ohio Senator Tom Niehaus, and OhioHealth Riverside Breast Health Center Call for Action on Breast Cancer 2Health News:Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019 2Health News:Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019 3Health News:Latest Study Says Statins Don't Slow Alzheimer's 2Health News:Scripps research scientists find new genetic mutation that halts the development of lupus 2Health News:Scripps research scientists find new genetic mutation that halts the development of lupus 3
... HPLC system designed to provide fast and ... aid in the comprehensive identification and quantitation ... glycemic control., ,The A1c assay combines the ... accuracy of boronate affinity columns. The result ...
... fastest blood gas analyzers for ... on the market. Equally suitable ... testing. The Roche COMPACT ... reliable assessment of acid-base status ...
... sets the standard for testing blood ... at your patient's side - the ... self contained system can easily be ... ICU, or wherever you need it ...
Flatbed Agitator....
Medicine Products: